GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Central Pharmaceutical JSC No.3 (HSTC:TW3) » Definitions » Cash-to-Debt

Central Pharmaceutical JSC No.3 (HSTC:TW3) Cash-to-Debt : 0.00 (As of . 20)


View and export this data going back to 2016. Start your Free Trial

What is Central Pharmaceutical JSC No.3 Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Central Pharmaceutical JSC No.3's cash to debt ratio for the quarter that ended in . 20 was 0.00.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Central Pharmaceutical JSC No.3 couldn't pay off its debt using the cash in hand for the quarter that ended in . 20.

The historical rank and industry rank for Central Pharmaceutical JSC No.3's Cash-to-Debt or its related term are showing as below:

HSTC:TW3's Cash-to-Debt is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.02
* Ranked among companies with meaningful Cash-to-Debt only.

Central Pharmaceutical JSC No.3 Cash-to-Debt Historical Data

The historical data trend for Central Pharmaceutical JSC No.3's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Central Pharmaceutical JSC No.3 Cash-to-Debt Chart

Central Pharmaceutical JSC No.3 Annual Data
Trend
Cash-to-Debt

Central Pharmaceutical JSC No.3 Semi-Annual Data
Cash-to-Debt

Competitive Comparison of Central Pharmaceutical JSC No.3's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Central Pharmaceutical JSC No.3's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Central Pharmaceutical JSC No.3's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Central Pharmaceutical JSC No.3's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Central Pharmaceutical JSC No.3's Cash-to-Debt falls into.


;
;

Central Pharmaceutical JSC No.3 Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Central Pharmaceutical JSC No.3's Cash to Debt Ratio for the fiscal year that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

Central Pharmaceutical JSC No.3's Cash to Debt Ratio for the quarter that ended in . 20 is calculated as:

Do not have enough data to calculate Cash to Debt ratio.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Central Pharmaceutical JSC No.3  (HSTC:TW3) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


Central Pharmaceutical JSC No.3 Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Central Pharmaceutical JSC No.3's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Central Pharmaceutical JSC No.3 Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
115 Ngo Gia Tu, Hai Chau 1 Ward, Hai Chau District, Danang, VNM
Central Pharmaceutical JSC No.3 is a pharmaceutical company. The company is engaged in the manufacture and sale of drugs, pharmaceutical chemicals, and medicinal herbs. Some of its products include Censamin; Ceteco Leflox and others.

Central Pharmaceutical JSC No.3 Headlines

No Headlines